OtherDrug Discovery and Translational Medicine
Mechanistic analysis of an ERK2-interacting compound that inhibits mutant-BRAF expressing melanoma cells by inducing oxidative stress
Ramon Martinez, Weiliang Huang, Ramin Samadani, Bryan Mackowiak, Garrick Centola, Lijia Chen, Ivie L Conlon, Kellie Hom, Maureen A. Kane, Steven Fletcher and Paul Shapiro
Journal of Pharmacology and Experimental Therapeutics October 27, 2020, JPET-AR-2020-000266; DOI: https://doi.org/10.1124/jpet.120.000266
Ramon Martinez
1University of Maryland, Baltimore, United States of America
Weiliang Huang
2Department of Pharmaceutical Sciences, University of Maryland, Baltimore - School of Pharmacy, United States of America
Ramin Samadani
2Department of Pharmaceutical Sciences, University of Maryland, Baltimore - School of Pharmacy, United States of America
Bryan Mackowiak
3Pharmaceutical Sciences, University of Maryland School of Pharmacy, United States of America
Garrick Centola
2Department of Pharmaceutical Sciences, University of Maryland, Baltimore - School of Pharmacy, United States of America
Lijia Chen
2Department of Pharmaceutical Sciences, University of Maryland, Baltimore - School of Pharmacy, United States of America
Ivie L Conlon
2Department of Pharmaceutical Sciences, University of Maryland, Baltimore - School of Pharmacy, United States of America
Kellie Hom
2Department of Pharmaceutical Sciences, University of Maryland, Baltimore - School of Pharmacy, United States of America
Maureen A. Kane
2Department of Pharmaceutical Sciences, University of Maryland, Baltimore - School of Pharmacy, United States of America
Steven Fletcher
2Department of Pharmaceutical Sciences, University of Maryland, Baltimore - School of Pharmacy, United States of America
Paul Shapiro
4Department of Pharmaceutical Science, University of Maryland, Baltimore - School of Pharmacy, United States of America
Data Supplement
- Supplemental Data -
Supplemental methods, references, 4 tables, and 7 figures.